Available Technologies   //   Invention Disclosure
Introducing Polsky On Demand, a new online portal of Polsky's world-class business and entrepreneurship workshops
Learn more
Polsky Teams with National Labs, NSF’s I-Corps to Support Midwest Deep Tech Ecosystem
1 / 5
Polsky Teams with National Labs, NSF’s I-Corps to Support Midwest Deep Tech Ecosystem
Quevos Lands $200,000 Investment on ABC's Shark Tank from KIND Snacks Founder Daniel Lubetzky
2 / 5
Quevos Lands $200,000 Investment on ABC's Shark Tank from KIND Snacks Founder Daniel Lubetzky
Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program
3 / 5
Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program
Electrochaea Produces Clean, Renewable Methane Using Catalyst Developed at UChicago
4 / 5
Electrochaea Produces Clean, Renewable Methane Using Catalyst Developed at UChicago
F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher
5 / 5
F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher

Get Started with the Polsky Center

Featured

Polsky Teams with National Labs, NSF’s I-Corps to Support Midwest Deep Tech Ecosystem

Read More
See All Podcasts
News //

Patent of the Week: A Predictive Gene Signature for Breast Cancer Therapy

Inventors, including University of Chicago researcher Edwardine Labay, have patented a seven-gene signature that can be used to assess the risk of breast cancer progression and treatment response. The…
News //

Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment

More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American…
News //

How Researchers are Returning Sensation to Mastectomy Patients

News //

25 Chicago Startups That Are Fighting Cancer

There are more than 100 types of cancer, and about 40% of men and women will be diagnosed with cancer at some point in their lifetime, according to the National…
News //

Eric Lefkofsky’s Tempus Will Use Data to Help UChicago Battle Breast Cancer

Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the University of Chicago data to help better treat breast cancer patients. Read more.

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept